|
WO1980000964A1
(en)
*
|
1978-11-03 |
1980-05-15 |
American Cyanamid Co |
Anti-inflammatory agents including 2-carbonyl-3-hydroxy-2-alkenonitriles
|
|
US4181677A
(en)
*
|
1978-12-13 |
1980-01-01 |
American Cyanamid Company |
2-Benzoyl-3-alkoxy-2-alkenonitriles
|
|
US4173650A
(en)
*
|
1978-11-03 |
1979-11-06 |
American Cyanamid Company |
Cis-2-benzoyl-3-hydroxy-2-alkenonitriles as anti-inflammatory agents
|
|
US4259256A
(en)
*
|
1978-12-13 |
1981-03-31 |
American Cyanamid Company |
2-Benzoyl-3-dimethylamino-2-alkenonitriles
|
|
IL60269A
(en)
*
|
1979-06-11 |
1983-12-30 |
Ciba Geigy |
Alpha-carbamoyl-pyrrolpropionitriles,their preparation and pharmaceutical compositions containing them
|
|
US4256759A
(en)
*
|
1979-06-11 |
1981-03-17 |
Ciba-Geigy Corporation |
Alphacarbamoyl-pyrrolpropionitriles
|
|
US4277420A
(en)
*
|
1979-09-24 |
1981-07-07 |
Monsanto Company |
Ephedrine and pseudoephedrine precursors
|
|
US4254049A
(en)
*
|
1979-12-17 |
1981-03-03 |
American Cyanamid Company |
Substituted phenyl-2-cyano-2-alkenoic acid esters
|
|
US4254047A
(en)
*
|
1979-12-17 |
1981-03-03 |
American Cyanamid Company |
Substituted phenyl-2-cyano-2-thioalkenoic acid esters
|
|
US4254048A
(en)
*
|
1979-12-17 |
1981-03-03 |
American Cyanamid Company |
Substituted phenyl alkylidene acetoacetonitriles
|
|
US4435407A
(en)
|
1982-01-07 |
1984-03-06 |
Ciba-Geigy Corporation |
Certain substituted β-oxo-α-carbamoylpyrrolepropionitriles
|
|
US4644010A
(en)
*
|
1982-09-28 |
1987-02-17 |
Ciba-Geigy Corporation |
Certain β-oxo-α-carbamoylpyrrolepropionitriles
|
|
DE3247454A1
(de)
*
|
1982-12-22 |
1984-06-28 |
Laboratorios Bago S.A., Buenos Aires |
Substituierte 3-phenyl-5-methyl-isoxazol-4-carboxy-anilide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
DE3534440A1
(de)
*
|
1985-09-27 |
1987-04-02 |
Hoechst Ag |
Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
|
|
US5268382A
(en)
*
|
1985-09-27 |
1993-12-07 |
Hoechst Aktiengesellschaft |
Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
|
|
GB8619432D0
(en)
*
|
1986-08-08 |
1986-09-17 |
Lilly Industries Ltd |
Pharmaceutical compounds
|
|
GB8619433D0
(en)
*
|
1986-08-08 |
1986-09-17 |
Lilly Industries Ltd |
Pharmaceutical compounds
|
|
US4888357A
(en)
*
|
1988-01-26 |
1989-12-19 |
Bristol-Myers Company |
Antiarthritic β-cycloalkyl-β-oxopropionitriles
|
|
US4975462A
(en)
*
|
1988-07-29 |
1990-12-04 |
Bristol-Myers Company |
Antiarthritic α-arylcarbamoyl cyanoacetic acid derivatives
|
|
DD297328A5
(de)
|
1989-08-18 |
1992-01-09 |
�������@���������k���Kk�� |
5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
|
|
US5583150A
(en)
*
|
1989-08-18 |
1996-12-10 |
Alcon Laboratories, Inc. |
5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases
|
|
US5034410A
(en)
*
|
1989-10-11 |
1991-07-23 |
Syntex (U.S.A.) Inc. |
Anthelmintically active benzenepropanamide derivatives
|
|
DE59010701D1
(de)
*
|
1990-05-18 |
1997-05-22 |
Hoechst Ag |
Isoxazol-4-carbonsäureamide und hydroxyalkyliden-cyanessigsäureamide, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
ZA913762B
(en)
|
1990-05-18 |
1992-01-29 |
Hoechst Ag |
Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides,pharmaceuticals containing these compounds and their use
|
|
DE59108123D1
(de)
*
|
1990-12-24 |
1996-10-02 |
Hoechst Ag |
Verfahren zur Acylierung von Alkoholen mit einem immobilisierten Pseudomonas-Lipase
|
|
US6133301A
(en)
*
|
1991-08-22 |
2000-10-17 |
Aventis Pharma Deutschland Gmbh |
Pharmaceuticals for the treatment of rejection reactions in organ transplantations
|
|
DE4127737A1
(de)
|
1991-08-22 |
1993-02-25 |
Hoechst Ag |
Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
|
|
IL102790A
(en)
*
|
1991-09-17 |
1996-01-31 |
Roussel Uclaf |
3-Cycloalkyl-prop-2- enamide derivatives
|
|
ES2079765T3
(es)
*
|
1991-10-23 |
1996-01-16 |
Hoechst Ag |
Derivados de amidas de acido n-fenil-2-ciano-3-hidroxicrotonico y su utilizacion como medicamento con propiedad inmunomoduladora.
|
|
GB9200275D0
(en)
*
|
1992-01-08 |
1992-02-26 |
Roussel Lab Ltd |
Chemical compounds
|
|
GB9209330D0
(en)
*
|
1992-04-30 |
1992-06-17 |
Roussel Lab Ltd |
Chemical compounds
|
|
GB9300083D0
(en)
|
1993-01-05 |
1993-03-03 |
Roussel Lab Ltd |
Chemical compounds
|
|
TW314467B
(da)
*
|
1993-03-31 |
1997-09-01 |
Hoechst Ag |
|
|
ES2108460T3
(es)
|
1993-06-03 |
1997-12-16 |
Therapeutic Antibodies Inc |
Fragmentos de anticuerpos en terapeutica.
|
|
GB9313365D0
(en)
*
|
1993-06-29 |
1993-08-11 |
Roussel Lab Ltd |
Chemical compounds
|
|
GB9322781D0
(en)
*
|
1993-11-04 |
1993-12-22 |
Roussel Lab Ltd |
Aromatic amides
|
|
LT3589B
(en)
|
1993-11-30 |
1995-12-27 |
Hoechst Ag |
Using of known combination for treatment of rejection reaction by transplantation of organs
|
|
US5700823A
(en)
*
|
1994-01-07 |
1997-12-23 |
Sugen, Inc. |
Treatment of platelet derived growth factor related disorders such as cancers
|
|
US5519042A
(en)
*
|
1994-01-13 |
1996-05-21 |
Hoechst Aktiengesellschaft |
Method of treating hyperproliferative vascular disease
|
|
US6331555B1
(en)
|
1995-06-01 |
2001-12-18 |
University Of California |
Treatment of platelet derived growth factor related disorders such as cancers
|
|
DE19539638A1
(de)
*
|
1995-10-25 |
1997-04-30 |
Hoechst Ag |
Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen
|
|
DE19547648A1
(de)
|
1995-12-20 |
1997-06-26 |
Hoechst Ag |
Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
|
|
US5981536A
(en)
*
|
1996-07-31 |
1999-11-09 |
Hoechst Aktiengesellschaft |
Use of xanthine derivatives for the modulation of apoptosis
|
|
US5856330A
(en)
*
|
1996-07-31 |
1999-01-05 |
Hoechst Aktiengesellschaft |
Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
|
|
US6011051A
(en)
*
|
1996-07-31 |
2000-01-04 |
Hoechst Aktiengesellschaft |
Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
|
|
US6316479B1
(en)
|
1997-05-19 |
2001-11-13 |
Sugen, Inc. |
Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
|
|
DK0987256T3
(da)
*
|
1997-08-08 |
2002-02-11 |
Aventis Pharma Gmbh |
Krystalform af N-(4-trifluormethylphenyl)-5-methylisoxazol-4-carboxylsyreamid
|
|
US6355678B1
(en)
*
|
1998-06-29 |
2002-03-12 |
Parker Hughes Institute |
Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
|
|
US20050255071A1
(en)
*
|
1998-12-10 |
2005-11-17 |
Aventis Pharma Deutschland Gmbh |
Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitors
|
|
GB0123571D0
(en)
*
|
2001-04-05 |
2001-11-21 |
Aventis Pharm Prod Inc |
Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
|
|
DE10132308A1
(de)
*
|
2001-07-06 |
2003-01-30 |
Aventis Behring Gmbh |
Kombinationspräparat zur Therapie von immunologischen Erkrankungen
|
|
WO2003006424A1
(en)
|
2001-07-10 |
2003-01-23 |
4Sc Ag |
Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
|
|
US20050158371A1
(en)
*
|
2002-02-12 |
2005-07-21 |
Sumitomo Pharmaceuticals Co., Ltd. |
Novel external agent
|
|
AU2003299316A1
(en)
|
2002-12-23 |
2004-07-14 |
4Sc Ag |
Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
|
|
UA108760C2
(uk)
|
2010-07-01 |
2015-06-10 |
|
Кальцієві солі сполуки як протизапальні, імуномодулюючі та антипроліферативні засоби
|
|
WO2015077535A2
(en)
|
2013-11-22 |
2015-05-28 |
Genzyme Corporation |
Novel methods for treating neurodegenerative diseases
|
|
AU2016280243B2
(en)
*
|
2015-06-17 |
2020-12-03 |
Biocon Limited |
A novel process for the preparation of teriflunomide
|
|
IL277326B2
(en)
|
2018-03-16 |
2024-03-01 |
Immunic Ag |
Calcium salt polymorph inhibitors of dihydroorotate dehydrogenase and processes for preparing same
|
|
JP2023522245A
(ja)
|
2020-04-21 |
2023-05-29 |
イミュニック アクチェンゲゼルシャフト |
ウイルス性疾患の治療又は予防において使用するためのビドフルジムス
|